Bayer logo

Bayer

Last updated January 31, 2026
432
Innovation Areas
13,147
Inventors
104
Collaborations

Radionuclide impurity and targeting insufficiency: BayerRecent Research Landscape

Low binding affinity and rapid clearance of monomeric tracers limit diagnostic sensitivity and therapeutic efficacy. Increasing valency through multimeric structures overcomes poor target residence time.